Efficacy of bivalent vaccines of porcine circovirus type 2 and <i>Mycoplasma hyopneumoniae</i> in specific pathogen-free pigs challenged with porcine circovirus type 2d-Reference-Cited by-同舟云学术

Efficacy of bivalent vaccines of porcine circovirus type 2 and Mycoplasma hyopneumoniae in specific pathogen-free pigs challenged with porcine circovirus type 2d

Published:2022 Issue:3 Volume:23 Page:
ISSN:1229-845X
Container-title:Journal of Veterinary Science
language:en
Short-container-title:J Vet Sci

Author:

Lim Jeonggyo¹²^ORCID,Jin Myongha²^ORCID,Yoon Injoong²^ORCID,Yoo Han Sang¹³^ORCID

Affiliation:

1. Department of Infectious Diseases, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea.

2. Choong Ang Vaccine Laboratories Co., Ltd., Daejeon 34055, Korea.

3. BK21 FOUR Future Veterinary Medicine Leading Education and Research Center, Seoul National University, Seoul 08826, Korea.

Funder

Rural Development Administration

Seoul National University

Publisher

The Korean Society of Veterinary Science

Subject

General Veterinary

Link

https://vetsci.org/pdf/10.4142/jvs.21287

Reference37 articles.

1. A review of porcine circovirus 2-associated syndromes and diseases

2. Porcine Circovirus Type 2–Associated Disease: Update on Current Terminology, Clinical Manifestations, Pathogenesis, Diagnosis, and Intervention Strategies

3. Phylogenetic characterization of porcine circovirus type 2 in PMWS and PDNS Korean pigs between 1999 and 2006

4. Phylogenetic analysis of porcine circovirus type 2 (PCV2) between 2015 and 2018 in Henan Province, China

5. Genotypic diversity of porcine circovirus type 2 (PCV2) and genotype shift to PCV2d in Korean pig population

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Our Understanding and Challenges of Viral Vaccines against Swine Pathogens;Viruses;2024-05-24

2. A porcine circovirus type 2d-based virus-like particle vaccine induces humoral and cellular immune responses and effectively protects pigs against PCV2d challenge;Frontiers in Microbiology;2024-01-11

3. A Field Efficacy Trial of Recombinant Porcine Circovirus Type 2d Vaccine in Three Herds;Vaccines;2023-09-16

4. High levels of maternally derived antibodies do not significantly interfere with the development of humoral and cell-mediated responses to Porcine circovirus 2 after intradermal vaccination;Porcine Health Management;2023-09-15

5. Selection and Evaluation of Porcine circovirus (PCV) 2d Vaccine Strains to Protect against Currently Prevalent PCV2;Vaccines;2023-09-01